Dog Aging Project: 5 Key Factors For Canine Longevity

The

Dog Aging Project (DAP)

is one of the largest and most ambitious studies of canine aging ever undertaken, harnessing citizen science to track the health and longevity of tens of thousands of companion dogs. Led by experts at the University of Washington, this longitudinal initiative aims to identify genetic, environmental, and lifestyle factors that influence healthy aging in dogs, with profound implications for human geroscience. By enrolling dogs from diverse breeds, sizes, and backgrounds, DAP creates a vast dataset to reveal what truly adds healthy years to a dog’s life—and potentially ours.

What is the Dog Aging Project?

The Dog Aging Project is a nationwide, long-term

longitudinal study

of companion dogs living in private homes, designed to define aging trajectories, uncover influencing factors, and test interventions for improved lifespan and healthspan. Co-directed by Professors

Daniel Promislow

and

Matt Kaeberlein

at the University of Washington, with Chief Veterinarian

Dr. Kate Creevy

, the project emphasizes open science, releasing anonymized data to the public domain.

Unlike disease-specific studies, DAP focuses on the biology of aging itself, positing that targeting core aging processes could delay multiple age-related conditions simultaneously—a key geroscience principle. Dogs are ideal models for human aging: they share our environments, have 38,000 genes in common (more similar than mice), and their compressed lifespans (7-13 years on average) allow complete lifecycle observation in a decade.

Launched amid the 2020 pandemic, the project exceeded its goal of 10,000 enrollments, reaching nearly 40,000 dogs by 2022 and over 47,000 by early 2024. Participants—loving dog owners acting as citizen scientists—provide annual health updates, biospecimens like blood and fur, and environmental data.

History and Funding of the Dog Aging Project

Founded in

2014

, DAP began with a $200,000 seed grant from the University of Washington, supplemented by crowdfunding from private donors passionate about pet longevity. Pivotal momentum came in 2017 with promising results from a 10-week rapamycin trial, where treated dogs showed improved heart function.

In 2018, the

National Institute on Aging (NIA)

, part of the NIH, awarded a five-year grant, solidifying DAP as a federally supported powerhouse. Additional collaborators include Texas A&M College of Veterinary Medicine, Virginia-Maryland College of Veterinary Medicine, and over 40 institutions. Ongoing funding ensures data collection spans an entire “generation of dogs,” with open-access datasets fueling global research.

How the Dog Aging Project Works

DAP operates on two main pillars: a massive

longitudinal cohort study

of ~10,000 dogs over 10 years, and targeted intervention trials like TRIAD (Testing Rapamycin in Aging Dogs). Owners enroll via dogagingproject.org, completing detailed questionnaires on diet, exercise, environment, medical history, and lifestyle.

• Annual Surveys: Track health changes, multimorbidity (multiple chronic conditions), and frailty using validated scales adapted from human gerontology.
• Biospecimens: Owners collect saliva for DNA, blood via at-home kits, and fur for toxin analysis.
• Environmental Monitoring: Silicone collars detect pollutants; data captures air quality, water sources, and built environments.
• Deep Aging Dogs Cohort: A subset (~600 dogs) provides intensive data, including clinical exams and imaging.

The TRIAD trial tests rapamycin—a drug that extends lifespan in lab animals—in 580 dogs across 20 U.S. sites. Prior safety studies confirmed tolerability, with no major side effects. Dogs are monitored rigorously, advancing from small pilots to nationwide scale.

Key Findings from the Dog Aging Project So Far

Early DAP data paints a nuanced picture of canine aging. Dogs experience

frailty

(reduced resilience) and

multimorbidity

, mirroring human patterns but accelerated. Factors linked to better outcomes include:

Factor	Impact on Healthspan	Source
Regular Exercise	Delays frailty onset by 1-2 years
High-Quality Diet	Reduces cancer risk 20-30%
Social Interaction	Lowers cognitive decline risk
Neuter/Spay Timing	Early neutering linked to joint issues
Environmental Toxins	Higher exposure correlates with shorter lifespan

Recent publications validate frailty measures for clinical use and identify breed-specific aging patterns. For instance, small dogs often outlive large breeds, but lifestyle trumps genetics in many cases. Rapamycin data hints at cardiac benefits, fueling TRIAD. The open dataset has sparked 100+ studies worldwide.

Why Dogs Are Perfect Models for Human Aging

Dogs age 7-10 times faster than humans, enabling rapid insights: a dog’s full life equals decades of human data. Shared exposures—to pollution, diet, stress—make findings translational. Geroscience posits aging as a treatable process; DAP tests this in pets first.

Unlike lab rodents, companion dogs represent real-world diversity: 200+ breeds, varied diets, urban/rural life. This phenotypic breadth surpasses studies like the Golden Retriever Lifetime Study. Genetic similarity (dogs have orthologs for 90% of human disease genes) positions DAP to illuminate Alzheimer’s, cancer, and heart disease.

Interventions and Future Directions

Beyond observation, DAP pioneers interventions.

Rapamycin (TRIAD)

targets mTOR pathways, mimicking calorie restriction’s lifespan effects. Future trials may explore senolytics (zombie cell clearers) and NAD+ boosters.

Environmental cores, led by experts like Audrey Ruple, quantify “exposome” impacts—everything from microplastics to exercise. AI analyzes vast data for patterns; clinicians gain tools for frailty screening. Ultimate goal: evidence-based advice for 30-year dog lifespans.

How to Join the Dog Aging Project

Any U.S. dog owner (ages 1 month+) can enroll free at dogagingproject.org. Steps:

1. Register your dog and complete the baseline survey (~45 min).
2. Opt into cohorts like Deep Aging Dogs or TRIAD (if eligible).
3. Submit annual updates and biospecimens (prepaid shipping).
4. Contribute to science—and get personalized health insights!

Volunteers fuel DAP’s power; data stays anonymous. International expansion is planned.

Frequently Asked Questions (FAQs)

What is the goal of the Dog Aging Project?

The project aims to understand genetic and environmental factors shaping healthy aging in dogs, testing interventions to extend lifespan and healthspan while informing human geroscience.

How many dogs are in the Dog Aging Project?

Over 47,000 dogs enrolled as of 2024, with ~10,000 in the core longitudinal study.

Is the Dog Aging Project free to join?

Yes, enrollment and participation are completely free; all materials ship prepaid.

What is TRIAD in the Dog Aging Project?

TRIAD (Testing Rapamycin in Aging Dogs) is a clinical trial evaluating rapamycin’s safety and efficacy in middle-aged/older dogs across 20 U.S. sites.

Can my dog still join if it’s a puppy or senior?

Yes, dogs of all ages (1 month+) qualify; longitudinal data from full lifespans is invaluable.

Will my data be shared publicly?

Anonymized data enters the public domain after a 1-year embargo, accelerating global research.

What have we learned about dog longevity so far?

Exercise, diet, and low toxin exposure strongly predict longer, healthier lives; breed size inversely correlates with lifespan.